Weighted Average Number of Shares Outstanding, Basic of NAVIDEA BIOPHARMACEUTICALS, INC. from 31 Dec 2015 to 30 Sep 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
NAVIDEA BIOPHARMACEUTICALS, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2015 to 30 Sep 2023.
  • NAVIDEA BIOPHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2023 was 99,364,154, a 223% increase year-over-year.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 30,901,869, a 5.3% increase from 2021.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 29,343,542.
  • NAVIDEA BIOPHARMACEUTICALS, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2018 was 170,535,343, a 5.5% increase from 2017.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 99,364,154 +68,632,153 +223% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 48,242,642 +17,973,784 +59% 01 Apr 2023 30 Jun 2023 10-Q 11 Aug 2023 2023 Q2
Q1 2023 32,654,012 +2,446,266 +8.1% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 30,901,869 +1,558,327 +5.3% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
Q3 2022 30,732,001 +609,452 +2% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2023 Q3
Q2 2022 30,268,858 +1,151,026 +4% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 30,207,746 +2,141,450 +7.6% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 29,343,542 01 Oct 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 30,122,549 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 29,117,832 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 28,066,296 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2019 10,017,848 +1,904,397 +23% 01 Jan 2019 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 170,535,343 +8,942,774 +5.5% 01 Oct 2018 31 Dec 2018 10-K 15 Mar 2019 2018 FY
Q3 2018 166,855,420 +4,848,774 +3% 01 Jul 2018 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 162,716,988 +806,196 +0.5% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 8,113,451 -152,263,025 -95% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 161,592,569 +6,170,185 +4% 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 162,006,646 +6,525,368 +4.2% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2018 Q3
Q2 2017 161,910,792 +6,528,424 +4.2% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018 2018 Q2
Q1 2017 160,376,476 +5,068,382 +3.3% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 155,422,384 01 Oct 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 155,481,278 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 155,382,368 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 155,308,094 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1

NAVIDEA BIOPHARMACEUTICALS, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 30,901,869 +1,558,327 +5.3% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2023 2022 FY
2021 29,343,542 01 Jan 2021 31 Dec 2021 10-K 27 Mar 2023 2022 FY
2018 170,535,343 +8,942,774 +5.5% 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2019 2018 FY
2017 161,592,569 +6,170,185 +4% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 155,422,384 +4,242,162 +2.8% 01 Jan 2016 31 Dec 2016 10-K 15 Mar 2018 2017 FY
2015 151,180,222 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.